Where does Svelte Medical Systems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Svelte Medical Systems, Inc. ranks #33,489 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Svelte Medical Systems, Inc. hold?

Svelte Medical Systems, Inc. holds 8 US utility patents granted between 2015 and 2019, spanning 4 technology areas.

What is Svelte Medical Systems, Inc.'s Innovation Score?

Svelte Medical Systems, Inc. has an Innovation Score of 29.7 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Svelte Medical Systems, Inc.'s patent grant rate increasing or decreasing?

Svelte Medical Systems, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Svelte Medical Systems, Inc.'s patents?

Svelte Medical Systems, Inc.'s patents average 29.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Svelte Medical Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Svelte Medical Systems, Inc.

Q: What technology areas does Svelte Medical Systems, Inc. focus on?

Svelte Medical Systems, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 7 patents. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Svelte ranks #33,489 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.

#33,489
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.7/100): 29.4
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33489 · US Corporation #33,489 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #33,489/49,997
PHOTO-FINISH SureFlap
CPC-NARROW A61F · 4 areas
INNOV-THIN 29.7/100
CLAIMS-DENSE 29.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: SureFlap Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Svelte Medical Systems · this assignee

30
3D Lighting… · lowest

7

What this shows Svelte's Innovation Score is 29.7/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Svelte's grants concentrate

Svelte Medical Systems, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 87.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2019. By volume, Svelte sits between SureFlap Ltd. and SymphonyAI Sensa LLC.

Sureflap

8
Surround IO

8
Suturion AB

8
Suzhou Suncadia B…

8
Swipesense

8
Swivel-link

8
Sybase 365

8
Symphonyai Sensa

8
Svelte Medical Sy… ◀

8

What this shows Svelte holds 8 patents at rank #33,485, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Svelte

By rank, the assignees closest to #33,485 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Svelte's primary technology class.

Svelte's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Svelte Medical Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	37.5%
2016	2	25.0%
2017	2	25.0%
2019	1	12.5%

Which technologies does Svelte Medical Systems, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 7

Y10T - Technical Subjects Covered BY Former US Classification 7

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#33,489

of 49,997 tracked assignees

Innovation Score

29.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Svelte Medical Systems, Inc.'s patent record in context - here's where to go next.

Svelte Medical Systems, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 87.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #33,489 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Svelte Medical Systems, Inc. against SureFlap Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.